Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01646
Species: Homo sapiens
Position : chr11:2233643-2234213
Year: 2022
Title: Chromatin state dynamics confers specific therapeutic strategies in enhancer subtypes of colorectal cancer.
Genome Build: hg19
Enhancer Type: Enhancer
Condition: Disease
Disease Name: colorectal adenocarcinoma
PMID:  34059508
MONDO: MONDO:0005008
Tissue: colon
Tissue Ontology ID: UBERON:0001155
Cell Source: HCT116/LS513/SW620 HiChIP context
CVCL ID: CVCL_0291
Cell Type: malignant cell
Cell Ontology ID: CL:0001064
Experiment Type: Tumor-specific enhancer mapping; chromatin interaction assay; CRISPR epigenomic perturbation
High Throughput Method: H3K27ac/H3K4me1/H3K4me3/H3K79me2/H3K27me3/H3K9me3 ChIP-seq; RNA-seq; H3K27ac HiChIP
Low Throughput Method: dCas9-KRAB enhancer repression; H3K27ac ChIP-qPCR; 3C; RT-qPCR; proliferation assay
About Target Gene
Target gene : ASCL2
About TF
TF name : NA
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Enhancer Associated Network
Overlapping Enhancers (hg19) 5 found
Enhancer ID Position Tissue Cell Disease
E_03318 chr11:2219531-2239062 lung malignant cell Lung Cancer
E_01649 chr11:2223156-2236495 colon malignant cell colorectal adenocarcinoma
E_01618 chr11:2233643-2234213 colon epithelial cell colorectal adenocarcinoma
E_01645 chr11:2233643-2234213 colon malignant cell colorectal adenocarcinoma
E_03295 chr11:2234046-2237062 colon malignant cell colorectal cancer
Expression of Target Genes for the Enhancer